MCM
AVDL

MAI Capital Management’s Avadel Pharmaceuticals AVDL Stock Holding History

MAI Capital Management’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Hold
0
– -$21.6K – 5021
2025
Q4 		– Hold
0
– – – 2468
2025
Q3 		– Hold
0
– – – 1660
2025
Q2 		– Hold
0
– – – 2212
2025
Q1 		– Hold
0
– – – 2113
2024
Q4 		– Hold
0
– – – 2004

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

MAI Capital Management's AVDL Position: Q1 2026 in Review

MAI Capital Management sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 23,968 shares — an estimated $517K sold.

MAI Capital Management first reported a position in AVDL in Q2 2023 and held it in 11 quarters. The position peaked at $1.89M in Q1 2024. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • MAI Capital Management reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • MAI Capital Management sold 23,968 Avadel Pharmaceuticals shares in Q1 2026, an estimated $517K.
  • MAI Capital Management first reported a position in Avadel Pharmaceuticals in Q2 2023 and held it in 11 quarters.
  • MAI Capital Management's Avadel Pharmaceuticals position peaked at $1.89M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.